Related Experiment Videos
Postinfarction unstable angina. Pathophysiologic basis for current treatment modalities
R C Becker1, J M Gore, J S Alpert
1Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester 01655.
Insights
Unstable angina, a critical heart condition, involves plaque rupture and clot formation. Prompt medical and interventional therapies are crucial for managing this acute coronary syndrome and preventing severe outcomes.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Unstable angina is a severe acute coronary syndrome.
- It stems from atherosclerotic plaque rupture, platelet aggregation, thrombus formation, and coronary spasm.
- Postinfarction angina patients are a high-risk group with increased mortality and infarct extension risk.
Purpose of the Study:
- To outline the pathophysiology and clinical management of unstable angina.
- To highlight the importance of early intervention in high-risk patients.
Main Methods:
- Review of clinical presentation and pathological mechanisms.
- Discussion of current therapeutic strategies, including medical management and revascularization.
Main Results:
- Unstable angina requires prompt identification and management of exacerbating factors.
- Medical therapy includes nitrates, beta-blockers, calcium channel blockers, aspirin, and heparin.
- Thrombolytic therapy can rapidly stabilize patients.
- Percutaneous transluminal coronary angioplasty and coronary artery bypass grafting are options for refractory or indicated cases.
Conclusions:
- Effective management of unstable angina involves a multi-faceted approach.
- Timely medical and interventional therapies are essential to reduce mortality and morbidity.
Abstract:
Unstable angina is an acute coronary syndrome characterized by the rapid progression of clinical symptoms which may culminate in acute myocardial infarction, infarct extension or sudden death. The pathologic substrate involves atherosclerotic plaque rupture with platelet deposition, thrombus formation and coronary arterial spasm. Patients with postinfarction angina represent a high-risk subgroup with severe multivessel disease, compromised collateral vessels and/or partially occlusive thrombi; their risk of infarct extension and death is significantly increased. Initial therapy includes nitrates, beta-adrenergic blockers, calcium channel antagonists, aspirin and possibly i.v. heparin, as well as prompt identification and control of exacerbating factors. Thrombolytic therapy may assume a more central role based on its ability to achieve rapid clinical stabilization. Percutaneous transluminal coronary angioplasty and coronary artery bypass grafting may be used emergently in patients refractory to medical therapy, or electively when clinically indicated.